Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 26,641 | 29,631 | 30,640 | 22,968 | 19,742 |
| Operating Income | -26,641 | -29,631 | -30,640 | -22,968 | -19,742 |
| Other Income | 4,878 | -138 | 1,615 | 7,074 | 2,387 |
| Pre-tax Income | -21,763 | -29,769 | -29,025 | -15,894 | -17,355 |
| Net Income Continuous | -21,763 | -29,769 | -29,025 | -15,894 | -17,355 |
| Net Income | $-21,763 | $-29,769 | $-29,025 | $-15,894 | $-17,355 |
| EPS Basic Total Ops | -158.00 | -376.75 | -5,704.65 | -221.14 | -659.67 |
| EPS Basic Continuous Ops | -158.02 | -376.71 | -5,704.86 | -221.66 | -660.68 |
| EPS Diluted Total Ops | -158.00 | -376.75 | -5,704.65 | -221.14 | -659.67 |
| EPS Diluted Continuous Ops | -158.02 | -376.71 | -5,704.86 | -221.66 | -660.68 |
| EPS Diluted Before Non-Recurring Items | -158.00 | -376.75 | -378.55 | -314.85 | -659.68 |
| EBITDA(a) | $-26,515 | $-29,504 | $-30,510 | $-22,804 | $-19,542 |